ABUS

Arbutus Biopharma Corp

NasdaqAdd to watchlist

Healthcare · Biotechnology

$5.12

−$0.05−0.97%

Delayed · 2026-09-10T20:00:00.000Z · marketstack

Aug 11, 2026$5.12

+$0.45+9.64%over 1M

Day range31% of range

$5.10$5.17

Session

Previous close: $5.17
Open: $5.11
Volume: 2.45M
Avg volume: -
Day high: $5.17
Day low: $5.10

Fundamentals

Visualize fundamentals and more

Market cap: 1.01B
P/E ratio: 6.61
EPS (TTM): $0.78
Dividend yield: -
Beta: 0.62
Shares outstanding: 197.47M

Source SEC EDGAR · 9/11/2026

Risk factors, year on year

Item 1AMarch 2026 10-KMarch 2025as filed.

added: 31
dropped: 33
re-drafted: 39

Out of 179 passages in this year’s Item 1A.

The assistant has not been given these passages. It will say so, and say what opens them. This costs you no question.

New this year

In addition to the aggregate $950.0 million Noncontingent Settlement Payment due to us and Genevant, the Moderna Settlement Agreement provides for a Contingent Settlement Payment of up to an aggregate $1.3 billion to us and Genevant, which is payable in full …

63 more passages, included withBespoke

Recent activity

21 more events, included withMeasure

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Companies like Arbutus Biopharma Corp

Also filed under Biotechnology, ranked by how closely they sit beside ABUS.

MRNAModerna, Inc.
ALNYALNYLAM PHARMACEUTICALS, INC.
REGNREGENERON PHARMACEUTICALS, INC.
VRTXVERTEX PHARMACEUTICALS INC / MA
INSMINSMED Inc
ARGXARGENX SE

Ask about Arbutus Biopharma Corp

The assistant answers from what ABUS has actually filed: 15 annual reports filed with the SEC and 3 funds that hold it. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.

Pressing one answers it here, from ABUS's filings and figures. One a day without an account; a free account has its own, and no card.

See every investor holding Arbutus Biopharma Corp, and every quarter they moved.

Ten seconds, no card, and nothing to cancel.

What an account lets you do with Arbutus Biopharma Corp

Separate the decisions from the paperwork
Every Form 4 ABUS insiders have filed, with vesting and automatic tax sales struck out: what's left is the buys and sells somebody actually chose to make.
Every filingMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: who added, who trimmed, who walked away.
Every position they holdMeasure
Interrogate the filing, not the internet
Ask anything about Arbutus Biopharma Corp's fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.

Create a free accountSee what the paid plans add

Free, no card, and it does not expire.